论文部分内容阅读
肺癌是当今世界上对人类健康与生命危害最大的恶性肿瘤之一,其死亡率居各类恶性肿瘤所致死亡的首位。世界卫生组织(World Health Organization,WHO)预测,到2025年中国每年将有超过一百万新发肺癌患者[1]。最新统计数据[2,3]显示,肺癌的总5年生存率仅10%-16%,而I期患者的5年生存率可达65%-75%。
Lung cancer is one of the most malignant tumors in human health and lives in the world today. Its mortality rate is the highest among all kinds of malignant tumors. The World Health Organization (WHO) predicts that by the year 2025, China will have over 1 million new-onset lung cancer patients every year [1]. The latest statistics [2,3] show that the overall 5-year survival rate of lung cancer is only 10% -16%, while the I-phase 5-year survival rate of 65% -75%.